No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DRIO240816C2500
- 0.04
- 0.000.00%
15min DelayClose Jul 19 15:50 ET
0.00High0.00Low
0.04Open0.04Pre Close0 Volume400 Open Interest2.50Strike Price0.00Turnover206.55%IV111.67%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.1469Delta0.3477Gamma30.00Leverage Ratio-0.0029Theta0.0001Rho4.41Eff Leverage0.0007Vega
Intraday
- 5D
- Daily
News
Express News | DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
Express News | Dario Expands GLP-1 Solution Client Base With New Employer Contract
Blue Shield of California Celebra El 5o Aniversario De Wellvolution, Su Galardonada Plataforma Digital De Salud, Y Suma Programas Nuevos Para El Control Del Peso Y La Diabetes
Más de 355,000 miembros de Blue Shield of California tienen acceso a servicios de medicina del estilo de vida para prevenir y tratar sus enfermedades crónicas, bajar de peso y mejorar su bienestar
Express News | DarioHealth Announces Two New Studies Presented At ADA Scientific Sessions; Research Confirms Sustainable Behavior Change Over 12 Months With Dario Digital Platform; 31% Of Dario Members With Type 2 Diabetes Achieve Diabetes Remission; Analysis...
Express News | Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Maintains Target Price $5
TD Cowen analyst Charles Rhyee maintains $DarioHealth(DRIO.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 47.4% and a total
Comments
$DarioHealth(DRIO.US$ Reuters· just
DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
$DarioHealth(DRIO.US$
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...
1
$DarioHealth(DRIO.US$ Enveric Biosciences Q1 Net Income USD -2.46 Million
DarioHealth Q1 Net Loss $(7.2)M Compared To $(12.8)M YoY
DarioHealth Corp Qtrly Shr Loss $0.20
DarioHealth Q1 Revenue USD 1.791 Million
DarioHealth Q1 Net Loss $(7.2)M Compared To $(12.8)M YoY
DarioHealth Corp Qtrly Shr Loss $0.20
DarioHealth Q1 Revenue USD 1.791 Million
1
$DarioHealth(DRIO.US$ Dario's Cardiometabolic Announces Contract To Provide Cardiometabolic Solutions To Regional Union; Financial Terms Not Disclosed
Moomoo 24/7· 3 mins ago![]()
Moomoo 24/7· 3 mins ago
$DarioHealth(DRIO.US$ National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health![]()
Read more